Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany flag Germany · Delayed Price · Currency is EUR
0.0010
0.00 (0.00%)
At close: Jan 23, 2026

FRA:9RP Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
16.611.7831.939.6428.4712.55
Cash & Short-Term Investments
16.611.7831.939.6428.4712.55
Cash Growth
54.59%-63.12%231.30%-66.15%126.81%403.45%
Accounts Receivable
-1.09--0.10.76
Other Receivables
0.740.961.250.970.490.27
Receivables
0.742.051.250.970.591.03
Prepaid Expenses
0.470.770.380.090.110.07
Other Current Assets
-0-0.050.171.59
Total Current Assets
17.8114.633.5510.7429.3315.24
Property, Plant & Equipment
0.270.230.050.070.1-
Total Assets
18.0814.8233.610.8229.4315.24
Accounts Payable
1.164.772.433.495.291.11
Accrued Expenses
0.972.051.773.351.071
Other Current Liabilities
0.870.240.960.110.110.15
Total Current Liabilities
2.997.065.166.956.472.26
Other Long-Term Liabilities
00-0---
Total Liabilities
2.997.065.166.956.472.26
Common Stock
2.40.5914.252.281.10.53
Additional Paid-In Capital
162.31131.59127.55102.8285.3934.86
Retained Earnings
-149.61-124.41-113.36-101.23-63.52-22.41
Comprehensive Income & Other
-0-00---
Shareholders' Equity
15.097.7628.453.8722.9612.98
Total Liabilities & Equity
18.0814.8233.610.8229.4315.24
Net Cash (Debt)
16.611.7831.939.6428.4712.55
Net Cash Growth
54.59%-63.12%231.30%-66.15%126.81%403.45%
Net Cash Per Share
0.070.090.500.663.162.84
Filing Date Shares Outstanding
605.93148.33126.4220.249.734.73
Total Common Shares Outstanding
605.93148.33126.4220.249.734.73
Working Capital
14.827.5428.43.822.8712.98
Book Value Per Share
0.020.050.220.192.362.74
Tangible Book Value
15.097.7628.453.8722.9612.98
Tangible Book Value Per Share
0.020.050.220.192.362.74
Machinery
-0.360.120.120.12-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.